Clinical trialNCT07029399RecruitingPhase 1Interventional

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

SponsorNiKang Therapeutics, Inc.Enrollment361CCNE1 Amplified Advanced Solid TumorsHR+ Breast CancerHR+ HER2- Breast CancerTriple Negative Breast Cancer (TNBC)

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

City of Hope
Duarte, California, United States
Hope Rugo, MD
Recruiting
Uc San Diego Moores Cancer Center
La Jolla, California, United States
Rebecca Shatsky, MD
Recruiting
Sarah Cannon Research Institute at Healthone
Denver, Colorado, United States
Gerald Falchook, MD
Recruiting
Yale Cancer Center
New Haven, Connecticut, United States
Adriana Kahn, MD
Recruiting
Scri Florida Cancer Specialists - Sarasota
Sarasota, Florida, United States
Judy Wang, MD
Recruiting
University of Iowa
Iowa City, Iowa, United States
Mark Burkard, MD
Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Antonio Giordano, MD
Recruiting
South Texas Accelerated Research Therapeutics (start) Midwest
Grand Rapids, Michigan, United States
Manish Sharma
Recruiting
Washington University
St Louis, Missouri, United States
Faisal Fa'ak, MD
Recruiting
Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
Fadi Braiteh, MD
Recruiting
Cleveland Clinic
Cleveland, Ohio, United States
Azka Ali, MD
Recruiting
Upmc Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
Marija Balic, MD, PhD, MBA
Recruiting
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Nisha Unni, MD
Recruiting
Md Anderson Cancer Center
Houston, Texas, United States
Timothy Yap, MD
Recruiting
South Texas Accelerated Research Therapeutics (start) San Antonio
San Antonio, Texas, United States
Amita Patnaik
Recruiting
South Texas Accelerated Research Therapeutics (start) Mountain Region
West Valley City, Utah, United States
William McKean
Recruiting
Next Virginia
Fairfax, Virginia, United States
Alexander Spira
Recruiting
West Virginia University
Morgantown, West Virginia, United States
Bei Jiang, MD, PhD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Fulvestrant →Letrozole →NKT5097 CDK2 →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 25 Mar 2025
Primary completion: 31 Jul 2027
Completion: 31 Dec 2027
Last update posted: 26 Jun 2026
Registered enrollment: 361
Registry id: NCT07029399

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.